Relay Therapeutics Ownership | Who Owns Relay Therapeutics?
Relay Therapeutics Ownership Summary
Relay Therapeutics is owned by 95.90% institutional investors, 1.32% insiders, and 2.78% retail investors. Sb investment advisers (uk) is the largest institutional shareholder, holding 16.29% of RLAY shares. BB Biotech AG Ord is the top mutual fund, with 4.41% of its assets in Relay Therapeutics shares.
RLAY Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Relay Therapeutics | 95.90% | 1.32% | 2.78% |
| Sector | Healthcare Stocks | 42.50% | 10.81% | 46.69% |
| Industry | Biotech Stocks | 45.24% | 10.75% | 44.01% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Sb investment advisers (uk) | 27.90M | 16.29% | $145.66M |
| Commodore capital lp | 17.00M | 9.93% | $88.74M |
| Point72 asset management | 14.77M | 8.63% | $77.12M |
| Blackrock funding, inc. /de | 13.76M | 8.03% | $71.82M |
| Blackrock | 10.54M | 7.94% | $68.74M |
| Casdin capital | 11.34M | 6.62% | $59.20M |
| Vanguard group | 9.40M | 5.49% | $49.05M |
| Bellevue group | 8.35M | 4.87% | $43.56M |
| Tang capital management | 8.07M | 4.71% | $42.12M |
| Norges bank | 5.78M | 4.12% | $23.82M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Casdin capital | 11.34M | 4.94% | $59.20M |
| Commodore capital lp | 17.00M | 4.33% | $88.74M |
| Nextech invest | 3.85M | 3.06% | $20.08M |
| Foresite capital management iv | 1.00M | 2.86% | $5.22M |
| Nextech invest | 3.85M | 2.57% | $15.85M |
| Bioimpact capital | 2.28M | 1.95% | $11.92M |
| Tang capital management | 8.07M | 1.62% | $42.12M |
| Kynam capital management, lp | 2.89M | 1.12% | $15.07M |
| Sb investment advisers (uk) | 27.90M | 1.10% | $145.66M |
| Bellevue group | 8.35M | 0.91% | $43.56M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Norges bank | 5.78M | 0.00% | 5.78M |
| Commodore capital lp | 17.00M | 4.33% | 3.65M |
| Tcg crossover management | 1.81M | 0.46% | 1.81M |
| Point72 asset management | 14.77M | 0.13% | 1.33M |
| Blackrock | 10.54M | 0.00% | 746.46K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Jpmorgan chase | 462.38K | 0.00% | -3.88M |
| Braidwell lp | - | - | -3.50M |
| Eventide asset management | - | - | -2.68M |
| Finepoint capital lp | - | - | -2.12M |
| Price t rowe associates inc /md/ | 1.14M | 0.00% | -1.74M |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Norges bank | 5.78M | 0.00% | 5.78M | $23.82M |
| Tcg crossover management | 1.81M | 0.46% | 1.81M | $9.45M |
| Srs capital advisors | 15.06K | 0.00% | 15.06K | $78.60K |
| Captrust financial advisors | 14.11K | 0.00% | 14.11K | $48.82K |
| 49 wealth management | 13.10K | 0.01% | 13.10K | $68.39K |
Sold Out
| Holder | Change |
|---|---|
| Tfc financial management | -1.00 |
| Capital performance advisors llp | -11.00 |
| Nelson, van denburg & campbell wealth management group | -18.00 |
| First command advisory services | -25.00 |
| Massmutual trust co fsb/adv | -28.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2025 | 192 | -3.52% | 164,241,668 | -1.23% | 95 | 1.02% | 79 | -25.47% | 63 | 26.00% |
| Jun 30, 2025 | 203 | -3.33% | 170,787,021 | 4.95% | 99 | 1.08% | 106 | -3.64% | 54 | -5.26% |
| Mar 31, 2025 | 13 | -93.60% | 21,465,711 | -86.91% | 12 | 0.09% | 8 | -93.89% | 2 | -94.44% |
| Dec 31, 2024 | 192 | -3.52% | 130,207,976 | -17.33% | 92 | 0.74% | 123 | 4.24% | 35 | -22.22% |
| Sep 30, 2024 | 198 | 11.24% | 157,463,305 | 24.21% | 112 | 1.23% | 118 | 20.41% | 45 | -6.25% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| BB Biotech AG Ord | 7.38M | 4.41% | - |
| Vanguard Total Stock Mkt Idx Inv | 5.17M | 3.01% | -114.66K |
| Vanguard US Total Market Shares ETF | 4.89M | 2.88% | 904.00K |
| iShares Russell 2000 ETF | 3.23M | 1.87% | - |
| Eventide Healthcare & Life Sciences I | 2.68M | 1.56% | - |
| JPMorgan Small Cap Growth A | 2.20M | 1.29% | 32.86K |
| SPDR® S&P Biotech ETF | 2.22M | 1.29% | 4.95K |
| Vanguard Small Cap Index | 2.02M | 1.18% | 7.50K |
| Belfius Equities Cure C Cap | 1.73M | 1.02% | - |
| Vanguard Institutional Extnd Mkt Idx Tr | 1.43M | 0.84% | -620.47K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Nov 03, 2025 | Patel Sanjiv | President and CEO | Sell | $434.51K |
| Oct 28, 2025 | Rahmer Peter | See remarks | Sell | $139.49K |
| Oct 29, 2025 | Rahmer Peter | See remarks | Sell | $160.46K |
| Oct 28, 2025 | Catinazzo Thomas | Chief Financial Officer | Sell | $157.93K |
| Oct 28, 2025 | Bergstrom Donald A | President, R&D | Sell | $225.24K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2025 Q4 | - | 5 |
| 2025 Q3 | - | 10 |
| 2025 Q2 | - | 12 |
| 2025 Q1 | - | 25 |
| 2024 Q4 | - | 12 |
RLAY Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools